Almaden Builds Business Operations to Catch up With Technology
June 28, 2023
Almaden Genomics building business operations to keep up with technological innovation
Read More »
Almaden Names Ellen Gordon VP, Head of Business Development
June 6, 2023
Almaden Genomics has named Ellen Gordon as VP, Head of Business Development. She will help Almaden partner with clients to accelerate genomic research.
Read More »
Almaden Genomics Names Board of Advisors
May 31, 2023
Almaden has announced its Board of Advisors, a highly regarded group of healthcare leaders with experience across a variety of industries.
Read More »
OmicsEdge Partners with Almaden to Streamline Drug Discovery
May 18, 2023
A new drug discovery service from OmicsEdge using Almaden's g.nome™ makes it easy for labs to quickly analyze a patient’s medical condition and genomics.
Read More »
Almaden Releases g.nome™ with Jupyter Notebook Integration
April 18, 2023
Almaden Genomics has updated its g.nome™ platform to integrate with Jupyter Notebook, which will further enable scientists to accelerate genomic discovery.
Read More »
Almaden Genomics Names David Gascoigne as CEO
January 25, 2023
Gascoigne, a life sciences industry veteran, will drive Almaden as it accelerates genomic research and discovery.
Read More »
Almaden Genomics Announces Launch of g.nome™ Platform
October 25, 2022
Almaden Genomics has launched g.nome™, a cloud-native platform designed to streamline genomic workflows and accelerate genomic discovery.
Read More »
Almaden Genomics Launches Spinoff From IBM Research
October 24, 2022
Almaden Genomics, a company with roots in an IBM Research laboratory in Silicon Valley, will publicly launch with the introduction of g.nome
Read More »